The Effect of Emotional Freedom Techniques Application on Patients With Cancer Phobia

December 31, 2025 updated by: Serafettin Okutan, Bitlis Eren University

Principal Investigator, Assistant Professor Şerafettin OKUTAN, Surgical Nursing, Faculty of Health Sciences, Bitlis Eren University

The aim is to examine the effect of Emotional Freedom Technique on death anxiety in patients with postoperative cancer phobia.

The hypotheses of the study are as follows:

H0: Emotional Freedom Technique has no effect on postoperative death anxiety in patients with cancer phobia.

H1: Emotional Freedom Technique has a positive effect on postoperative death anxiety in patients with cancer phobia.

Study Overview

Detailed Description

Intervention Group

After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided Emotional Freedom Technique (EFT) training to the patients and asked them to apply Emotional Freedom Technique. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

Control Group

After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being over 18 years of age,
  • Having had oncological surgery,
  • Having no visual or auditory problems,
  • Having no psychiatric problems.

Exclusion Criteria:

  • Not accepting to participate in the study or wanting to leave,
  • Being under 18 years of age,
  • Having been previously diagnosed with cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided EFT training to the patients and asked them to apply EFT. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

Emotional Freedom Technique application; It is an application that works on cognitive and energetic levels. Emotional Freedom Technique Application Instructions

  1. Determination of Subjective Units of Disturbance (SUD)
  2. Preparation or setup
  3. Application of appropriate acupuncture points in order
  4. 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously
  5. Application of appropriate acupuncture points in order again
  6. Control of the differentiation in the level of discomfort with Subjective Units of Disturbance again
No Intervention: Control Group
After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
death anxiety
Time Frame: After coming to the clinic after surgery and their condition becoming stable, the death anxiety scale was applied to the patients as a pre-test. Three days later, the death anxiety scale was applied as a post-test.

Death Anxiety Scale:

The scale developed by Templer was translated into Turkish by Sarıkaya and Baloğlu. The scale consists of 20 items. High scores indicate high death anxiety.

After coming to the clinic after surgery and their condition becoming stable, the death anxiety scale was applied to the patients as a pre-test. Three days later, the death anxiety scale was applied as a post-test.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Şerafettin OKUTAN, Dr., Bitlis Eren University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2025

Primary Completion (Actual)

September 28, 2025

Study Completion (Actual)

October 10, 2025

Study Registration Dates

First Submitted

February 2, 2025

First Submitted That Met QC Criteria

February 6, 2025

First Posted (Actual)

February 10, 2025

Study Record Updates

Last Update Posted (Actual)

January 5, 2026

Last Update Submitted That Met QC Criteria

December 31, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Emotional Freedom Technique

Subscribe